402 related articles for article (PubMed ID: 33467433)
1. PPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases.
Carvalho MV; Gonçalves-de-Albuquerque CF; Silva AR
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467433
[TBL] [Abstract][Full Text] [Related]
2. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
Becker J; Delayre-Orthez C; Frossard N; Pons F
Fundam Clin Pharmacol; 2006 Oct; 20(5):429-47. PubMed ID: 16968414
[TBL] [Abstract][Full Text] [Related]
3. PPARγ signaling and emerging opportunities for improved therapeutics.
Wang S; Dougherty EJ; Danner RL
Pharmacol Res; 2016 Sep; 111():76-85. PubMed ID: 27268145
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
6. PPAR Ligands Containing Stilbene Scaffold.
Fantacuzzi M; De Filippis B; Amoroso R; Giampietro L
Mini Rev Med Chem; 2019; 19(19):1599-1610. PubMed ID: 31161987
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target.
Mansure JJ; Nassim R; Kassouf W
Cancer Biol Ther; 2009 Apr; 8(7):6-15. PubMed ID: 19417560
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma is a new therapeutic target in sepsis and inflammation.
Zingarelli B; Cook JA
Shock; 2005 May; 23(5):393-9. PubMed ID: 15834303
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
Aleshin S; Strokin M; Sergeeva M; Reiser G
Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
[TBL] [Abstract][Full Text] [Related]
11. Astaxanthin as a Peroxisome Proliferator-Activated Receptor (PPAR) Modulator: Its Therapeutic Implications.
Choi CI
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31018521
[TBL] [Abstract][Full Text] [Related]
12. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
13. PPAR-gamma in ulcerative colitis: a novel target for intervention.
Bertin B; Dubuquoy L; Colombel JF; Desreumaux P
Curr Drug Targets; 2013 Nov; 14(12):1501-7. PubMed ID: 23651165
[TBL] [Abstract][Full Text] [Related]
14. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
15. The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity.
Yousefnia S; Momenzadeh S; Seyed Forootan F; Ghaedi K; Nasr Esfahani MH
Gene; 2018 Apr; 649():14-22. PubMed ID: 29369787
[TBL] [Abstract][Full Text] [Related]
16. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Takada I; Makishima M
Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
[No Abstract] [Full Text] [Related]
18. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
[TBL] [Abstract][Full Text] [Related]
19. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
20. Curcumin Attenuates Pulmonary Inflammation in Lipopolysaccharide Induced Acute Lung Injury in Neonatal Rat Model by Activating Peroxisome Proliferator-Activated Receptor γ (PPARγ) Pathway.
Cheng K; Yang A; Hu X; Zhu D; Liu K
Med Sci Monit; 2018 Feb; 24():1178-1184. PubMed ID: 29480285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]